Robins guided Q1 fiscal 2027 product revenue between $1.262 billion and $1.267 billion, representing 27% year-over-year growth. For full year fiscal 2027, product revenue is expected at approximately ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

Snowflake raised its fiscal 2026 forecast for product revenue on Wednesday, betting on strong demand for its data analytics services as enterprises prioritize artificial intelligence spending. The ...

Ardelyx (ARDX) on Thursday said 2025 total product revenue was approximately $378 million, representing 18% year-over-year growth. IBSRELA finished 2025 with full year revenue totaling approximately ...

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced strong preliminary, unaudited net product revenues for Q4 and full year 2024 of $201 million ...

Robins guided Q4 product revenue between $1.195 billion and $1.2 billion, representing 27% year-over-year growth, with a non-GAAP operating margin of 7%. Full FY26 product revenue guidance was raised ...

CEO Gary Gillheeney reported that Q3 sales exceeded the high end of guidance, driven by Advanced Wound Care product sales increasing 31% year-over-year and Surgical & Sports Medicine product sales ...

Cisco Systems Inc (NASDAQ: CSCO) is poised to report its Q3 FY’24 results on May 14, reporting on a quarter that is likely to see the company’s sales contract, as customers focus on deploying hardware ...

Preliminary Q4 2024 PEMGARDA™ (pemivibart) net product revenue reached $13.8 million, marking a 48% growth compared to Q3 2024. Total operating costs and expenses for Q4 2024 were approximately $32 ...

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) today announced preliminary product revenue for the fourth quarter and full-year 2024 and provided product revenue guidance for ...

Aaron Biggs, VP of Revenue at Summit, is a tenured technology leader with expertise in growth, go-to-market strategy and customer success. If you still think revenue is just a sales problem, I’ve got ...

Arcutis Biotherapeutics is a biopharmaceutical firm dedicated to creating and commercializing treatments for chronic skin conditions. Its primary product family, ZORYVE, features a range of topical ...